NASDAQ: APLMW - Apollomics, Inc.

Rentabilität für sechs Monate: -62.31%
Dividendenrendite: 0.00%

Aktionsplan Apollomics, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Apollomics, Inc.

Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc.

weitere details
was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2021-11-26
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Цена ао 0.026
Preisänderung pro Tag: -62.31% (0.026)
Preisänderung pro Woche: -62.31% (0.026)
Preisänderung pro Monat: -62.31% (0.026)
Preisänderung über 3 Monate: -62.31% (0.026)
Preisänderung über sechs Monate: -62.31% (0.026)
Preisänderung pro Jahr: -62.31% (0.026)
Preisänderung seit Jahresbeginn: -62.31% (0.026)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.27 6
P/BV 0.0451 10
P/E 0 0
EV/EBITDA 0.4657 10
Gesamt: 5.75

Effizienz

Name Bedeutung Grad
ROA, % -311.63 0
ROE, % -418.59 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.085 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -55.33 0
Rentabilität Ebitda, % 131.46 10
Rentabilität EPS, % 169.14 10
Gesamt: 6
Weitere Details

Institutionen Volumen Aktie, %
Ehp Funds Inc. 498450 4.82
Warberg Asset Management LLC 445600 4.31
Walleye Capital LLC 383744 3.71
BOOTHBAY FUND MANAGEMENT, LLC 373715 3.61
Yakira Capital Management, Inc. 362364 3.5
Shaw D.E. & Co., Inc. 318530 3.08
Context Capital Management, LLC 298500 2.88
MMCAP International, Inc. SPC 250000 2.42
Walleye Trading LLC 215856 2.09
Whitebox Advisors, LLC 200000 1.93

Adresse: , , - in Google Maps öffnen, Öffnen Sie Yandex-Karten